Ventricular tachycardia after naloxone administration in an adolescent.

Autor: Naber CE; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Acholonu NO; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Fernandes ND; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Sanders BP; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatric Emergency Medicine, Department of Pediatrics, Massachusetts General for Children at North Shore Medical Center, 57 Highland Avenue, Salem, MA 01970, United States., Sweetser L; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Flaherty MR; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Lahoud-Rahme M; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Division of Pediatric Cardiology, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States., Yager PH; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States; Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, 5(th) Floor, Boston, MA 02114, United States. Electronic address: pyager@mgh.harvard.edu.
Jazyk: angličtina
Zdroj: The American journal of emergency medicine [Am J Emerg Med] 2021 Nov; Vol. 49, pp. 300-301. Date of Electronic Publication: 2021 Jun 10.
DOI: 10.1016/j.ajem.2021.05.083
Abstrakt: Naloxone is a medication with a largely benign safety profile that is frequently administered in the emergency department to patients presenting with altered mental status. Ventricular tachycardia has been reported after naloxone administration in adult patients with prior use of opiate or sympathomimetic medications. However, no such reports exist in the pediatric population or in patients who have no known history of opiate or sympathomimetic medication use. We describe a case of ventricular tachycardia after naloxone administration in a 17-year-old male with no known prior use of opiate or sympathomimetic agents who presented to the emergency department with altered mental status of unknown etiology. Emergency physicians may wish to prepare for prompt treatment of ventricular arrythmias when administering naloxone to pediatric patients presenting with altered mental status.
Competing Interests: Declaration of Competing Interest None.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: